Abstract:
To determine accuracy of cord blood bilirubin in identifying conception or design of the work; or significant neonatal hyperbilirubinemia. the acquisition, analysis, or Methodology: A Cross sectional study was conducted in Pediatric department interpretation of data for the work, of Fauji Foundation Hospital Rawalpindi from Jan.2019 to June 2019. Cord Final approval of the version to be blood samples were sent for the blood group and bilirubin levels. Neonates published,2,4,5Drafting the work or with cord bilirubin level > 2mg/dl and 35 weeks of gestation were included in the Conflict of Interest: None study of which 35 (47.3%) were male and 39 (52.7%) were female (male: Received: May 25, 2022 female: 1:1.1). The data was analyzed using SPSS 17. At 3rd day of life mean ± Accepted: Jan 1, 2023 SD cord blood bilirubin was 8.4 ± 2.7 mg/dl, mean direct bilirubin was 1.6 ± 0.9 Address of Correspondent mg/dl and mean indirect bilirubin was 6.8 ± 2.3mg/dl. Significant Dr. Awais Tahir hyperbilirubinemia developed in 16 (21.6%) newborns at >35 weeks of Fauji Foundation Hospital, gestation, who had a cord blood bilirubin level of > 2 mg/dl, so that the dRoacwtaolrpsibnidn@iyahoo.com accuracy of cord blood bilirubin level (true positives) in determining significant hyperbilirubinemia was 21.6%. Conclusion: Cord blood bilirubin level >2mg/dl in all healthy term newborns predicts significant hyperbilirubinemia.